Results 121 to 130 of about 19,804 (171)

Opioid overdose associated with concomitant use of hydrocodone and selective serotonin reuptake inhibitors. [PDF]

BMC Med
Bea S, Huybrechts KF, Glynn RJ, Vine SM, Belitkar S, Bateman BT, Bykov K.   +6 more
europepmc   +1 more source

Hyperfiltration and Metabolism Before and After a Low-Calorie, Pre-Gastric Bypass Surgery Diet: Significance for Concentrations of Hydrophilic and Lipophilic Drugs. [PDF]

Basic Clin Pharmacol Toxicol
Axelsson MAB, Wallerstedt SM.
europepmc   +1 more source

Distinct genetic responses to fluoxetine sertraline and citalopram in mouse cortical neurons. [PDF]

iScience
Yamamoto H, Abe K.
europepmc   +1 more source

Absence of pharmacovigilance signals for bleeding events associated with warfarin-SSRI drug interactions: a comparative analysis of FAERS and CVARD databases. [PDF]

Ther Adv Drug Saf
Zhang P, Cheng S, Diao J, Zhu H.
europepmc   +1 more source

Effects of Different SSRIs on nNOS mRNA Expression in the Hippocampus and Prefrontal Cortex of Chronically Stressed Rats.

Neuropsychobiology
Zhang L, Su S, Yang JC, Zhang H, Kong FZ.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Citalopram

Human Psychopharmacology: Clinical and Experimental, 2000
Citalopram is a selective serotonin (5-HT) reuptake inhibitor (SSRI) developed by H. Lundbeck A/S in Denmark. It is the most selective serotonin antidepressant with proven efficacy, a favourable pharmacokinetic profile and a low potential for interactions with other concomitant medication.
Andre F., Joubert, Connie, Sánchez, Frank, Larsen   +2 more
openaire   +3 more sources